Kinases: Serine/threonine-specific protein kinases (EC 2.7.11-12)
|
|
Serine/threonine-specific protein kinases (EC 2.7.11.1-EC 2.7.11.20)
|
|
Non-specific serine/threonine protein kinases (EC 2.7.11.1)
|
LATS1, LATS2, MAST1, MAST2, STK38, STK38L, CIT, ROCK1, SGK, SGK2, SGK3, Protein kinase B (AKT1, AKT2, AKT3), Ataxia telangiectasia mutated, Mammalian target of rapamycin, EIF-2 kinases (PKR, HRI, EIF2AK3, EIF2AK4), Wee1 (WEE1)
|
|
Pyruvate dehydrogenase kinase (EC 2.7.11.2)
|
PDK1, PDK2, PDK3
|
|
Dephospho-(reductase kinase) kinase (EC 2.7.11.3)
|
AMP-activated protein kinase α (PRKAA1, PRKAA2) · β (PRKAB1, PRKAB2) · γ (PRKAG1, PRKAG2, PRKAG3)
|
|
(3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)) (EC 2.7.11.4)
|
BCKDK, BCKDHA, BCKDHB
|
|
(isocitrate dehydrogenase (NADP+)) kinase (EC 2.7.11.5)
|
IDH2, IDH3A, IDH3B, IDH3G
|
|
(tyrosine 3-monooxygenase) kinase (EC 2.7.11.6)
|
STK4
|
|
Myosin-heavy-chain kinase (EC 2.7.11.7)
|
Aurora kinase (Aurora A kinase, Aurora B kinase)
|
|
Fas-activated serine/threonine kinase (EC 2.7.11.8)
|
FASTK, STK10
|
|
Goodpasture-antigen-binding protein kinase (EC 2.7.11.9)
|
-
|
|
IκB kinase (EC 2.7.11.10)
|
CHUK, IKK2, TBK1, IKBKE, IKBKG, IKBKAP
|
|
cAMP-dependent protein kinase (EC 2.7.11.11)
|
Protein kinase A, PRKACG, PRKACB, PRKACA, PRKY
|
|
cGMP-dependent protein kinase (EC 2.7.11.12)
|
Protein kinase G, PRKG1
|
|
Protein kinase C (EC 2.7.11.13)
|
Protein kinase C, Protein kinase Cζ, PKC alpha, PRKCB1, PRKCD, PRKCE, PRKCH, PRKCG, PRKCI, PRKCQ, Protein kinase N1, PKN2, PKN3,
|
|
Rhodopsin kinase (EC 2.7.11.14)
|
Rhodopsin kinase
|
|
Beta adrenergic receptor kinase (EC 2.7.11.15)
|
Beta adrenergic receptor kinase, Beta adrenergic receptor kinase-2
|
|
G-protein coupled receptor kinases (EC 2.7.11.16)
|
GRK4, GRK5, GRK6
|
|
Ca2+/calmodulin-dependent (EC 2.7.11.17)
|
BRSK2, CAMK1, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CAMK4, MLCK, CASK, CHEK1, CHEK2, DAPK1, DAPK2, DAPK3, STK11, MAPKAPK2, MAPKAPK3, MAPKAPK5, MARK1, MARK2, MARK3, MARK4, MELK, MKNK1, MKNK2, NUAK1, NUAK2, OBSCN, PASK, PHKG1, PHKG2, PIM1, PIM2, PKD1, PRKD2, PRKD3, PSKH1, SNF1LK2, KIAA0999, STK40, SNF1LK, SNRK, SPEG, TSSK2, Kalirin, TRIB1, TRIB2, TRIB3, TRIO, Titin, DCLK1
|
|
Myosin light-chain kinase (EC 2.7.11.18)
|
MYLK, MYLK2, MYLK3, MYLK4
|
|
Phosphorylase kinase (EC 2.7.11.19)
|
PHKA1, PHKA2, PHKB, PHKG1, PHKG2
|
|
Elongation factor 2 kinase (EC 2.7.11.20)
|
EEF2K, STK19
|
|
|
|
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)
|
|
Polo kinase (EC 2.7.11.21)
|
PLK1, PLK2, PLK3, PLK4
|
|
Cyclin-dependent kinase (EC 2.7.11.22)
|
CDK1, CDK2, CDKL2, CDK3, CDK4, CDK5, CDKL5, CDK6, CDK7, CDK8, CDK9, CDK10, CDC2L5, CRKRS, PCTK1, PCTK2, PCTK3, PFTK1, CDC2L1
|
|
(RNA-polymerase)-subunit kinase (EC 2.7.11.23)
|
RPS6KA5, RPS6KA4, P70S6 kinase, P70-S6 Kinase 1, RPS6KB2, RPS6KA2, RPS6KA3, RPS6KA1, RPS6KC1
|
|
Mitogen-activated protein kinase (EC 2.7.11.24)
|
Extracellular signal-regulated (MAPK1, MAPK3, MAPK4, MAPK6, MAPK7, MAPK12, MAPK15), C-Jun N-terminal (MAPK8, MAPK9, MAPK10), P38 mitogen-activated protein (MAPK11, MAPK13, MAPK14)
|
|
MAP3K (EC 2.7.11.25)
|
MAP kinase kinase kinases (MAP3K1, MAP3K2, MAP3K3, MAP3K4, MAP3K5, MAP3K6, MAP3K7, MAP3K8) RAFs (ARAF, BRAF, KSR1, KSR2), MLKs (MAP3K12, MAP3K13, MAP3K9, MAP3K10, MAP3K11, MAP3K7, ZAK), CDC7, MAP3K14
|
|
Tau-protein kinase (EC 2.7.11.26)
|
TPK1, TTK, GSK-3
|
|
(acetyl-CoA carboxylase) kinase (EC 2.7.11.27)
|
-
|
|
Tropomyosin kinase (EC 2.7.11.28)
|
-
|
|
Low-density-lipoprotein receptor kinase (EC 2.7.11.29)
|
-
|
|
Receptor protein serine/threonine kinase (EC 2.7.11.30)
|
Bone morphogenetic protein receptors (BMPR1, BMPR1A, BMPR1B, BMPR2), ACVR1, ACVR1B, ACVR1C, ACVR2A, ACVR2B, ACVRL1, Anti-Müllerian hormone receptor
|
|
|
|
Dual-specificity kinases (EC 2.7.12)
|
|
MAP2K
|
MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7
|
|
|
|
- B
- enzm
- 1.1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 10
- 11
- 13
- 14
- 15-18
- 2.1
- 2.7.10
- 2.7.11-12
- 3.1
- 4.1
- 5.1
- 6.1-3
|
|
|
|